Ikoma, Japan

Bompei Yasui


Average Co-Inventor Count = 6.9

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Ikoma, JP (1983 - 1984)
  • Nara, JP (1985)

Company Filing History:


Years Active: 1983-1985

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Bompei Yasui: Innovator in Anti-Tumor Agents

Introduction

Bompei Yasui is a notable inventor based in Ikoma, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tumor agents. With a total of 4 patents to his name, Yasui's work has had a meaningful impact on cancer treatment.

Latest Patents

Yasui's latest patents include innovative compounds such as 2'-Deoxy-3',5'-di-O-alkylcarbonyl-5-fluorouridine derivatives. These derivatives are characterized by their strong anti-tumor activity coupled with weak toxicity. They are represented by a specific general formula, wherein R stands for an alkyl group, an alkoxy group, or a halogen atom. Another significant patent involves ester derivatives of alkoxybenzoyldeoxyfluorouridine, which are also designed for use as active ingredients in anti-tumor agents, particularly for oral administration.

Career Highlights

Throughout his career, Yasui has worked with prominent companies such as Funai Yakuhin Kogyo Co., Ltd. and Funai Kakuhin Kogyo Co., Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations.

Collaborations

Yasui has collaborated with notable colleagues, including Tomohisa Miyamoto and Setsuro Fujii. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Bompei Yasui's contributions to the field of anti-tumor agents highlight his innovative spirit and dedication to improving cancer treatment. His patents reflect a commitment to developing effective and safe pharmaceutical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…